Fulgent Genetics, Inc. Share Price & Technical Analysis
FLGT · $17.11 (-1.55%)
Healthcare / Diagnostics & Research
$17.11
-1.55%
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pat…
Price chart
Seasonality
May has 4 positive and 0 negative years (last 5 years shown)
22% return in May, 19% avg return in past 3 year May month.
-18% return in 2026, 4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 0% | -42% | 7% | -5% | 22% | – | – | – | – | – | – | – | -18% |
| 25 | -11% | -6% | 9% | 3% | 19% | -4% | -14% | 16% | 3% | 0% | 32% | -11% | 37% |
| 24 | -14% | -8% | -4% | -6% | 1% | -6% | 21% | -5% | -3% | 0% | -15% | 1% | -37% |
| 23 | 12% | -3% | -2% | -5% | 35% | -7% | 5% | -15% | -19% | -10% | 15% | 5% | 12% |
| 22 | -37% | -3% | 0% | -12% | 0% | 0% | 10% | -27% | -11% | 4% | -9% | -18% | -105% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Strong
Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$446.46M
P/E ratio
—
52W high
$31.04
52W low
$13.46
Volume
3,92,972
Beta
0.88
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Fulgent Genetics, Inc. share price today?
- Fulgent Genetics, Inc. (FLGT) last traded around $17.11 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does FLGT have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for FLGT. Download the app for real-time alerts.
- How can I analyze Fulgent Genetics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.